Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
< Back

'other' and 'unspecified hyperlipidemia' (ICD9CM: 272.4)
Run an advanced search on this term

Search within:  

Sort results by:      



Filter results by:

1-5 of 5  
 
1.  
The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. 2012 Jul (revised 2014 Oct). NGC:010590
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
2.  
Screening and management of hypercholesterolemia. 2003 Aug (revised 2013 Aug). NGC:010040
Michigan Quality Improvement Consortium - Professional Association. View all guidelines by the developer(s)
3.  
Screening for cardiovascular disease and risk factors. 2011 Mar. NGC:009530
Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
5.  
Clinical practice guideline on the management of lipids as a cardiovascular risk factor. 2008 Sep (reaffirmed 2013 Jun). NGC:007747
Basque Health System - Osakidetza - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-5 of 5